0000899243-21-005686.txt : 20210210 0000899243-21-005686.hdr.sgml : 20210210 20210210164651 ACCESSION NUMBER: 0000899243-21-005686 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210208 FILED AS OF DATE: 20210210 DATE AS OF CHANGE: 20210210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freedman Edward D. CENTRAL INDEX KEY: 0001817434 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39381 FILM NUMBER: 21614651 MAIL ADDRESS: STREET 1: C/O PANDION THERAPEUTICS, INC. STREET 2: 134 COOLIDGE AVE., 2ND FLOOR CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pandion Therapeutics, Inc. CENTRAL INDEX KEY: 0001807901 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 833015614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 134 COOLIDGE AVENUE STREET 2: 2ND FLOOR CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-393-5925 MAIL ADDRESS: STREET 1: 134 COOLIDGE AVENUE STREET 2: 2ND FLOOR CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: Pandion Therapeutics Holdco LLC DATE OF NAME CHANGE: 20200327 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-08 0 0001807901 Pandion Therapeutics, Inc. PAND 0001817434 Freedman Edward D. C/O PANDION THERAPEUTICS, INC., 134 COOLIDGE AVENUE WATERTOWN MA 02472 0 1 0 0 Chief Operating Officer Stock Option (right to buy) 17.75 2021-02-08 4 A 0 36895 0.00 A 2031-02-07 Common Stock 36895 36895 D This option award was granted on February 8, 2021. 1/4 of the shares underlying the award shall vest on February 8, 2022, with the remainder of the shares vesting in equal monthly installments following February 8, 2022 through February 8, 2025, subject to the reporting person's continued service on each applicable vesting date. /s/ Edward D. Freedman 2021-02-10